AMBP Q1 2026 Earnings Strong EPS Beat Overshadowed by Market Headwinds XWEL Q3 2023 Earnings Significant EPS Miss with No Reported Revenue IVVD Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress Oxford Lane Capital Corp 625 Series 2027 Term Preferred Shares OXLCP Q4 2025 Earnings EPS Misses Estimates by 74 as Shares Edge Higher BBAI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development